نتائج البحث - Paul‐Peter Tak

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    NF-κB Regulation by IκB Kinase in Primary Fibroblast-Like Synoviocytes

    NF-κB Regulation by IκB Kinase in Primary Fibroblast-Like Synoviocytes حسب Karlfried R. Aupperle, Brydon L. Bennett, David L. Boyle, Paul‐Peter Tak, Anthony M. Manning, Gary S. Firestein

    منشور في 1999
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis

    Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis حسب Christian Barthel, Nataliya Yeremenko, Reinhilde Jacobs, Reinhold Schmidt, Michael Bernateck, H. Zeidler, Paul‐Peter Tak, Dominique Baeten, Markus Rihl

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers

    Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers حسب Barry Bresnihan, Eliza Pontifex, Rogier M. Thurlings, Marjolein Vinkenoog, Hani El‐Gabalawy, Ursula Fearon, Oliver FitzGerald, Daniëlle M. Gerlag, Terence Rooney, Marleen G. van de Sande, Douglas J. Veale, Koen Vos, Paul‐Peter Tak

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients

    B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthri... حسب Stefan Bruijnen, Michel Tsang-A-Sjoe, Hennie G. Raterman, Tamara H. Ramwadhdoebé, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Marc C. Huisman, Otto S. Hoekstra, Paul-Peter Tak, Alexandre E. Voskuyl, Conny van der Laken

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis

    Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis حسب Jing Cui, Eli A. Stahl, Saedís Saevarsdóttir, Corinne Miceli‐Richard, Dorothée Diogo, Gosia Trynka, Towfique Raj, Maša Umićević Mirkov, Helena Canhão, Katsunori Ikari, Chikashi Terao, Yukinori Okada, Sara Wedrén, Johan Askling, Hisashi Yamanaka, Shigeki Momohara, Atsuo Taniguchi, Koichiro Ohmura, Fumihiko Matsuda, Tsuneyo Mimori, Namrata Gupta, Manik Kuchroo, Ann W. Morgan, John D. Isaacs, Anthony G. Wilson, Kimme L Hyrich, Marieke M. J. Herenius, Marieke E. Doorenspleet, Paul‐Peter Tak, J. Bart A. Crusius, Irene E. van der Horst‐Bruinsma, Gertjan Wolbink, Piet L. C. M. van Riel, Mart van de Laar, Henk‐Jan Guchelaar, Nancy A. Shadick, Cornelia F Allaart, T. Huizinga, René E. M. Toes, Robert P. Kimberly, S. Louis Bridges, Lindsey A. Criswell, Larry W. Moreland, João Eurico Fonseca, Niek de Vries, Barbara E. Stranger, Philip L. De Jager, Soumya Raychaudhuri, Michael E. Weinblatt, Peter K. Gregersen, Xavier Mariette, Anne Barton, Leonid Padyukov, Marieke J. H. Coenen, Elizabeth W. Karlson, Robert M. Plenge

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: